Does Insurance Cover TMS for Depression?

Table of Contents

• What Is TMS Therapy and Why Does It Matter for Coverage?
• TMS Therapy Insurance Requirements Most Plans Enforce
  • FDA-Cleared Conditions and Medical Necessity Standards
  • Mental Health Parity and What It Means for Your Plan
• Failed Antidepressant Trials for TMS: What Insurers Require
• The TMS Therapy Prior Authorization Process, Step by Step
  • Clinical Documentation Your Psychiatrist Will Need to Submit
• Does Insurance Cover TMS for Depression: Private Plans vs. Medicare
  • Medicare Part B Coverage for TMS
  • In-Network vs. Out-of-Network Cost Breakdown
• What to Do When Insurance Denies TMS for Depression
  • Filing a Formal Appeal
  • Maintenance Sessions and Ongoing Coverage
• Conclusion

Last Updated: August 12, 2026

What Is TMS Therapy and Why Does It Matter for Coverage?

Transcranial magnetic stimulation (TMS) is a non-invasive, FDA-cleared treatment that uses targeted magnetic pulses to stimulate specific brain regions associated with mood regulation. For people with major depressive disorder who haven’t responded adequately to antidepressant medications, TMS represents a meaningful clinical option, one that raises a practical question: does insurance cover TMS for depression, and what does it take to get approved?

At Solid Foundation Psychiatry, we work with patients navigating this question. The honest answer is: yes, most major insurance plans cover TMS for depression, but coverage is conditional, documentation-heavy, and far from automatic.

TMS matters for coverage discussions because it’s expensive out of pocket, and treatment typically spans several weeks of daily sessions. Insurance authorization is often the difference between accessible and unaffordable care. Understanding the coverage landscape before you begin saves time, reduces frustration, and positions you to advocate effectively.

TMS Therapy Insurance Requirements Most Plans Enforce

Most private insurance plans that cover TMS for depression apply consistent requirements before authorizing treatment. Core requirements include:

• A confirmed diagnosis of major depressive disorder
• Documentation of treatment-resistant depression, typically defined as failing to respond to a minimum number of antidepressant medication trials
• A psychiatric evaluation confirming TMS is clinically appropriate
• Use of an in-network provider with appropriate credentials
• Prior authorization approval before the first session

What varies between plans is how strictly each requirement is interpreted. Some insurers require two failed medication trials; others require four. Getting these specifics right at the documentation stage is critical, it’s the most common reason claims are delayed or denied.

FDA-Cleared Conditions and Medical Necessity Standards

TMS therapy is FDA-cleared for several conditions, which matters because insurers generally won’t cover treatments outside cleared indications without an exceptional showing of medical necessity. According to the FDA’s device clearance database, TMS has received clearance for major depressive disorder, obsessive-compulsive disorder, anxious depression, and smoking cessation, among other indications.

For insurance purposes, the most relevant clearance is for major depressive disorder in adults who have not responded adequately to prior antidepressant treatment. Medical necessity is the standard insurers apply: the treatment must be clinically appropriate, consistent with the patient’s diagnosis, and supported by evidence that other treatments have been tried and failed.

Mental Health Parity and What It Means for Your Plan

The Mental Health Parity and Addiction Equity Act requires that mental health benefits be no more restrictive than comparable medical or surgical benefits under the same plan. Your insurer cannot impose stricter prior authorization requirements, higher cost-sharing, or tighter visit limits on TMS for depression than they would for a comparable medical procedure.

As documented in CMS guidance on mental health parity enforcement, patients and providers have the right to request a comparative analysis showing how the plan applies its coverage criteria. If you believe your plan is applying stricter standards to TMS than to analogous medical treatments, that’s the basis for an appeal.

Failed Antidepressant Trials for TMS: What Insurers Require

Failed antidepressant trials for TMS refers to documented evidence that a patient took one or more antidepressant medications at an adequate dose, for an adequate duration, and still did not achieve sufficient symptom relief. Insurers use this requirement to establish that TMS is medically necessary rather than a first-line preference.

What counts as "adequate" varies:

• Dose: The medication must have been prescribed at a therapeutic dose, not a starting or sub-therapeutic level
• Duration: Most plans require at least four to eight weeks at that dose
• Number of trials: The minimum is typically two failed trials, but some plans require three or four
• Documentation: Pharmacy records, clinical notes, and prescriber documentation all count as evidence

A common mistake is assuming that a patient’s memory of past medication use is sufficient. Insurers want clinical records, and gaps in documentation are frequently cited as reasons for denial. If records from previous providers are incomplete, obtaining them before submitting the prior authorization request is essential.

The TMS Therapy Prior Authorization Process, Step by Step

The TMS therapy prior authorization process is the formal approval pathway your provider submits to your insurer before treatment begins. Starting treatment before approval is confirmed almost always results in denied claims.

Here is how the process typically works:

1. Benefit verification: Your provider’s office contacts your insurer to confirm TMS is a covered benefit and to identify exact coverage criteria.
2. Psychiatric evaluation: A licensed psychiatrist evaluates you and documents the diagnosis, symptom severity, and treatment history.
3. Medical records compilation: Your provider gathers records of prior antidepressant trials, therapy history, and relevant psychiatric evaluations.
4. Prior authorization submission: Your provider submits the authorization request with all required clinical documentation to your insurer.
5. Insurer review: Medical reviewers assess whether the request meets coverage criteria, typically taking several business days to a few weeks.
6. Decision notification: You and your provider receive approval, denial, or a request for additional information.
7. Treatment scheduling: If approved, sessions are scheduled within the authorized period.

Missing documentation, incomplete medication histories, or a psychiatric evaluation that doesn’t explicitly address the insurer’s specific criteria are the most common reasons for requests to be sent back.

Clinical Documentation Your Psychiatrist Will Need to Submit

The strength of the prior authorization request depends almost entirely on the quality of clinical documentation. A well-prepared submission tells a complete clinical story: who the patient is, what they’ve tried, why those treatments failed, and why TMS is appropriate.

Core documentation typically includes:

• DSM-5 diagnosis: A formal major depressive disorder diagnosis with documented symptom severity
• Treatment history: Detailed records of each failed antidepressant trial, including drug name, dose, duration, and reason for discontinuation
• Psychiatric evaluation notes: A current evaluation explicitly stating that TMS is medically necessary
• Referral documentation: Some plans require a referral from a primary care provider or psychiatrist before the TMS provider can submit
• Standardized assessment scores: Tools like the PHQ-9 quantify symptom severity

Insurers evaluate the paperwork, not the patient. A patient who has genuinely struggled with treatment-resistant depression can still be denied if the documentation doesn’t clearly articulate that clinical reality.

Book Appointment →

Does Insurance Cover TMS for Depression: Private Plans vs. Medicare

Does insurance cover TMS for depression across all plan types? Broadly, yes, but the structure of coverage differs between private insurance and government programs.

Private insurance plans, including employer-sponsored and marketplace plans, typically cover TMS for depression when the criteria above are met. Coverage criteria, cost-sharing, and the prior authorization process vary significantly between carriers. Calling the member services number on your insurance card and asking specifically about TMS coverage is the most reliable starting point.

Medicare Part B Coverage for TMS

Medicare Part B covers TMS for major depressive disorder as a physician-administered outpatient service when the treating provider accepts Medicare assignment and the patient meets clinical criteria, including a diagnosis of major depressive disorder and prior treatment history consistent with treatment-resistant depression.

According to Medicare’s outpatient mental health coverage guidelines, Part B covers certain brain stimulation therapies under specific billing codes. Patients are responsible for the standard Part B coinsurance after meeting their deductible, typically 20% of the Medicare-approved amount.

Medicaid coverage for TMS varies by state. Some state Medicaid programs cover TMS; others do not, or cover it only under limited circumstances. Checking with your state’s Medicaid office is the only reliable way to confirm current coverage.

In-Network vs. Out-of-Network Cost Breakdown

The in-network vs. out-of-network distinction significantly affects what you’ll actually pay for TMS therapy. Seeing an in-network TMS provider means the provider has a contracted rate with your insurer, and your cost-sharing applies at the lower in-network tier.

Seeing an out-of-network provider typically means higher coinsurance rates (often 30-50% vs. 10-20% in-network), a separate higher out-of-network deductible, and possible balance billing. For a treatment course spanning several weeks of daily sessions, the cost difference can be substantial.

What to Do When Insurance Denies TMS for Depression

A denial is not a final answer. Insurance denials for TMS typically fall into a few categories: insufficient documentation of failed medication trials, a determination that TMS is not medically necessary based on submitted records, or a finding that the specific diagnosis doesn’t meet the plan’s coverage criteria. The denial letter specifies the reason, which tells you exactly what to address in an appeal.

Filing a Formal Appeal

The appeals process for denied TMS claims follows a structured pathway, and patients have legal rights throughout it. Under the Affordable Care Act, insurers must provide a clear appeals process and respond within defined timeframes.

Steps to file a formal appeal:

1. Request the denial letter in writing if you haven’t received it, including the specific reason for denial and clinical criteria applied.
2. Request the plan’s coverage criteria for TMS in writing. Under mental health parity law, you’re entitled to the comparative analysis showing how these criteria were developed.
3. Work with your psychiatrist to prepare an appeal letter that directly addresses each stated reason for denial.
4. Gather additional supporting documentation: peer-reviewed literature on TMS clinical efficacy, letters of medical necessity from your treating psychiatrist, and assessment scores not included in the original submission.
5. Submit the internal appeal within the deadline specified in your denial letter, typically 180 days.
6. If the internal appeal is denied, request an external review. An independent organization reviews the insurer’s decision, and their finding is binding on the insurer in most states.

The CMS external appeals process guidance outlines patient rights under federal law for external review of denied claims. Many patients who appeal successfully do so at the external review stage, particularly when the denial was based on a medical necessity determination that a clinical reviewer disagrees with.

Maintenance Sessions and Ongoing Coverage

An underappreciated aspect of TMS coverage is what happens after the initial treatment course. Some patients achieve remission and maintain it long-term. Others experience a return of symptoms and may need additional TMS sessions, often called maintenance sessions or re-treatment.

Coverage for maintenance TMS sessions is less consistent than coverage for initial treatment. Many plans do not have an explicit policy for maintenance TMS, which means coverage decisions may be made on a case-by-case basis, often requiring a new prior authorization. If you’ve completed a successful TMS course and symptoms return, the documentation requirements for re-treatment are similar to the initial authorization: a current psychiatric evaluation, documented symptom recurrence, and a clinical rationale for why TMS is again appropriate.

Living with treatment-resistant depression while navigating insurance barriers is genuinely difficult, and no one should have to face that process alone. At Solid Foundation Psychiatry, our team provides personalized, evidence-based psychiatric care, including TMS therapy, and supports patients through every step of the insurance and prior authorization process. Our collaborative approach means your treatment plan is built around your specific history, not a generic protocol. If you’re ready to explore whether TMS is right for you, book an appointment with Solid Foundation Psychiatry and take the first step toward lasting relief.

This article was written using GrandRanker